The Priority Review

Tag

KBP-5074

1 story

Stories

  1. Clinical trials

    Novo Nordisk posts results of Phase 3 KBP-5074 trial in uncontrolled hypertension and CKD

    The study enrolled 666 participants and began on November 5, 2021, with primary completion on January 30, 2024. The trial was terminated and the results were first posted on ClinicalTrials.gov on November 4, 2026.